Position in NVAX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$796,733
+$249,709 QoQ
Shares Held
84,579
+25.9% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#73
of 263 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 2%
Shared 0%
None 98%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Derivatives in NVAX
reported options exposure · as of Jun 30, 2023CallValue
$1,091
CallShares
10,200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Creative Planning holds $452,608,635 across 219 Biotechnology names. NVAX ranks #96 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
127,672 | $63,418,511 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
36,949 | $23,039,178 | |
| 3 | EXEL |
Exelixis, Inc.
|
270,292 | $14,706,586 | |
| 4 | INCY |
Incyte Corp
|
110,664 | $12,544,870 | |
| 5 | CYTK |
Cytokinetics Inc
|
141,939 | $12,091,783 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
64,120 | $12,008,393 | |
| 7 | ARGX |
Argenx SE
|
12,744 | $11,823,500 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
153,161 | $8,763,872 |
All Filings in NVAX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $796,733 | 84,579 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $547,024 | 67,202 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $421,538 | 62,729 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $859,213 | 99,102 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $666,980 | 105,870 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $215,741 | 33,657 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $319,364 | 39,722 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $410,247 | 32,482 | Shares | Defined | 2024-10-11 | |
| 2024-06-30 | $305,649 | 24,143 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $102,535 | 21,451 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $91,968 | 19,160 | Shares | Sole | 2024-02-14 | |
| 2023-06-30 | $241,482 | 32,501 | Shares | Sole | 2023-07-21 | |
| 2023-06-30 | $1,091 | 10,200 | Call | Sole | 2023-07-21 | |
| 2023-03-31 | $86,929 | 12,544 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $112,195 | 10,914 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $257,748 | 14,162 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $527,568 | 10,258 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $677,064 | 9,193 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,074,455 | 7,510 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,568,300 | 7,565 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $1,597,420 | 7,524 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $27,272,650 | 150,420 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $17,206,104 | 154,301 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $13,859,698 | 127,916 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $7,777,221 | 93,308 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $1,050,711 | 77,372 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||